Prostate Cancer - Results from #28960

ASCO 2009 - Circulating Tumor Cells (CTC) in Patients with Metastatic Castration-Resistant Prostate Cancer (CRPC) Receiving Abiraterone Acetate (AA) after Failure of Docetaxel-Based Chemotherapy - Session Highlights June 1, 2009

Working patterns and perceived contribution of prostate cancer clinical nurse specialists: A mixed method investigation - Abstract April 20, 2009

The Efficacy and Safety of Degarelix: A 12-Month, Comparative, Randomized, Open-Label, Parallel-Group Phase III Study in Patients with Prostate Cancer - Abstract December 12, 2008

Is Abiraterone Acetate Well Tolerated and Effective in the Treatment of Castration-Resistant Prostate Cancer? - Abstract November 7, 2008

Metabolic and Cardiovascular Effects of Androgen Deprivation Therapy - Abstract September 8, 2008

ASCO 2008 Annual Meeting - Updated Analysis of a Phase II Study Using Sorafenib (S) for Metastatic Castrate-Resistant Prostate Cancer (mCRPC) August 22, 2008

ASCO 2008 Annual Meeting - Phase II Trial of Thalidomide (T), Bevacizumab (Bv), and Docetaxel (Doc) in Patients (pts) with Metastatic Castration-Refractory Prostate Cancer (mCRPC) August 21, 2008

ASCO 2008 Annual Meeting - Phase I Trial of Ipilimumab (IPI) Alone and in Combination with Radiotherapy (XRT) in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) August 19, 2008

ASCO 2008 Annual Meeting - Identification of an Androgen Withdrawal Responsive Phenotype in Castrate Resistant Prostate Cancer (CRPC) Patients (pts) Treated with Abiraterone Acetate (AA) August 13, 2008

ASCO 2008 Annual Meeting - Crossover Pharmacokinetics (PK) Study to Assess Oral Administration of Abiraterone Acetate Capsule and Tablet Formulations in Fasted and Fed States in Patients with Prostate Cancer August 13, 2008

ASCO 2008 Annual Meeting - Anti-Tumor Activity of Abiraterone Acetate (AA), a CYP17 Inhibitor of Androgen Synthesis, in Chemotherapy Naive and Docetaxel Pre-Treated Castration Resistant Prostate Cancer (CRPC) August 13, 2008

ASCO 2008 Annual Meeting - Abiraterone Acetate and Prednisone in Patients (Pts) with Progressive Metastatic Castration Resistant Prostate Cancer (CRPC) After Failure of Docetaxel-Based Chemotherapy August 13, 2008

The influence of developmental life stage on quality of life in survivors of prostate cancer and their partners - Abstract July 1, 2008

The Ultrastructure of Detrusor in Patients with Benign Prostatic Hyperplasia June 24, 2008

Is seeing a specialist nurse associated with positive experiences of care? The role and value of specialist nurses in prostate cancer care - Abstract April 11, 2008

GU Cancers Symposium - ASCO ASTRO SUO - 2008 - Preliminary Phase II Results of Abiraterone Acetate in Patients with Castration-resistant metastatic Prostate Cancer after Failure of Docetaxel-based Chemotherapy February 15, 2008

GU Cancers Symposium - ASCO ASTRO SUO - 2008 - Preliminary Phase II Results of Abiraterone Acetate in Patients with Castration-resistant metastatic Prostate Cancer after Failure of Docetaxel-based Chemotherapy February 15, 2008

Redefining Clinically Significant Castration Levels in Patients with Prostate Cancer Receiving Continuous Androgen Deprivation Therapy September 20, 2007

Statin Drugs and Risk of Advanced Prostate Cancer March 6, 2007

Page 1449 of 1449